BRCA1 and cancer: This disputes the risk of false-positive MSP results that may be caused by contamination by cancer cells when analyzing histologically normal adjacent tissues using the MSP technique; hence, any detected methylation in this type of tissue refers to the BRCA1 promoter methylation of normal cells.